An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Harvard University · Dana-Farber Cancer Institute · +8 more institutions
Abstract
In certain human cancers, the expression of critical oncogenes is driven from large regulatory elements, called super-enhancers, that recruit much of the cell's transcriptional apparatus and are defined by extensive acetylation of histone H3 lysine 27 (H3K27ac). In a subset of T-cell acute lymphoblastic leukemia (T-ALL) cases, we found that heterozygous somatic mutations are acquired that introduce binding motifs for the MYB transcription factor in a precise noncoding site, which creates a super-enhancer upstream of the TAL1 oncogene. MYB binds to this new site and recruits its H3K27 acetylase-binding partner CBP, as well as core components of a major leukemogenic transcriptional complex that contains RUNX1,…
Citation impact
- FWCI
- 30.44
- Percentile
- 100%
- References
- 46
Authors
15- MRMarc R. Mansour
Harvard University, Dana-Farber Cancer Institute, University College London
- BJBrian J. AbrahamCorresponding
Whitehead Institute for Biomedical Research
- LALars AndersCorresponding
Whitehead Institute for Biomedical Research
- ABAlla Berezovskaya
Harvard University, Dana-Farber Cancer Institute
- AGAlejandro Gutiérrez
Boston Children's Hospital, Harvard University, Dana-Farber Cancer Institute
Topics & keywords
- Enhancer
- Biology
- MYB
- Transcription factor
- Genetics
- Histone
- Enhancer RNAs
- Transcription (linguistics)
- Good health and well-being